Epstein–Barr virus microRNAs and lung cancer

[1]  F. Marincola,et al.  Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival , 2010, British Journal of Cancer.

[2]  Scott D Ramsey,et al.  Lung cancer histology, stage, treatment, and survival in American Indians and Alaska Natives and whites , 2010, Cancer.

[3]  F. Marincola,et al.  Evaluation of normalization methods for two-channel microRNA microarrays , 2010, Journal of Translational Medicine.

[4]  Jing Li,et al.  Secreted monocytic miR-150 enhances targeted endothelial cell migration. , 2010, Molecular cell.

[5]  A. Laganà,et al.  Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints , 2010, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

[6]  Loyal A Goff,et al.  Differential regulation of microRNA stability. , 2010, RNA.

[7]  Yingdong Zhao,et al.  Strengths and Limitations of Laboratory Procedures for MicroRNA Detection , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[8]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[9]  Yingdong Zhao,et al.  MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer , 2010, Clinical Cancer Research.

[10]  D. Flieder,et al.  Population-based trends in lung cancer incidence in women. , 2009, Seminars in oncology.

[11]  Raymond Wai-Ming Lung,et al.  Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. , 2009, Neoplasia.

[12]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[13]  Blossom Damania,et al.  Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. , 2009, Blood.

[14]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[15]  Ling Wang,et al.  Pre-Micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma , 2009, PLoS pathogens.

[16]  E. Tan,et al.  Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma. , 2009, Oncology reports.

[17]  David Y. Lu,et al.  Automated In Situ Hybridization and Immunohistochemistry for Cytomegalovirus Detection in Paraffin-embedded Tissue Sections , 2009, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  Katherine Cosmopoulos,et al.  Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma , 2008, Journal of Virology.

[19]  D. Kwong,et al.  An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival , 2008, The Journal of experimental medicine.

[20]  S. Wacholder,et al.  Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancer , 2008, BMC public health.

[21]  E. Engels.  Inflammation in the development of lung cancer: epidemiological evidence , 2008, Expert review of anticancer therapy.

[22]  Andrea J. O'Hara,et al.  EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. , 2008, Cancer research.

[23]  Andrea J. O'Hara,et al.  Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. , 2008, Blood.

[24]  Yuriy Gusev,et al.  Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. , 2007, RNA.

[25]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[26]  Yu Liang,et al.  BMC Genomics , 2007 .

[27]  B. O'Sullivan,et al.  Epstein–Barr virus-associated tumours: an update for the attention of the working pathologist , 2006, Journal of Clinical Pathology.

[28]  J. Kutok,et al.  Spectrum of Epstein-Barr virus-associated diseases. , 2006, Annual review of pathology.

[29]  Yuriy Gusev,et al.  Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.

[30]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[31]  M. Gulley,et al.  Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. , 2004, The Journal of molecular diagnostics : JMD.

[32]  E. Wit.  Design and Analysis of DNA Microarray Investigations , 2004, Human Genomics.

[33]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[34]  P. Chu,et al.  Epstein–Barr virus plays no role in the tumorigenesis of small-cell carcinoma of the lung , 2004, Modern Pathology.

[35]  H. Uchiyama,et al.  Lack of evidence for a role of Epstein-Barr virus in the increase of lung cancer in idiopathic pulmonary fibrosis. , 2003, Respiratory medicine.

[36]  M. Thun,et al.  Tobacco use and cancer: an epidemiologic perspective for geneticists , 2002, Oncogene.

[37]  P. Gattuso,et al.  Demonstration of Epstein-Barr virus in carcinomas of various sites. , 2002, Cancer research.

[38]  S. Natsugoe,et al.  Epstein‐Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms , 2001, Journal of medical virology.

[39]  P. Cagle,et al.  Absence of evidence for an etiologic role for Epstein-Barr virus in neoplasms of the lung and pleura. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[40]  S. Leung,et al.  In situ detection of Epstein–Barr virus in non‐small cell lung carcinomas , 1995, The Journal of pathology.

[41]  T. Kameya,et al.  Incidence of latent infection of Epstein–Barr virus in lung cancers—an analysis of EBER1 expression in lung cancers by in situ hybridization , 1994, The Journal of pathology.

[42]  A. Watne,et al.  Lymphoepithelioma‐like carcinoma of the lung , 1991, Journal of surgical oncology.

[43]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[44]  G. de‐Thé,et al.  Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas , 1979, International journal of cancer.

[45]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[46]  A. Schetter,et al.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. , 2010, Carcinogenesis.

[47]  K. Takada,et al.  Role of EBERs in the pathogenesis of EBV infection. , 2010, Advances in cancer research.

[48]  喜島 祐子.  Among various epithelial neoplasms,Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma , 2001 .

[49]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[50]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[51]  R. Chatterjee,et al.  Prevalence of serum IgG and IgM antibodies against Epstein-Barr virus capsid antigen in Indian patients with respiratory tract carcinomas. , 1994, Neoplasma.

[52]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.